Since HCV infection may lead to hepatocellular carcinoma (HCC) and vitamin D (deficiency) is related to cancer, we investigated if SNPs in genes involved in vitamin D pathway could predict HCV-related HCC presence in patients treated with new anti-HCV drugs.

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs

Cusato, Jessica
First
;
Boglione, Lucio;De Nicolò, Amedeo;Favata, Fabio;Ariaudo, Alessandra;Mornese Pinna, Simone;Avataneo, Valeria;Carcieri, Chiara;Di Perri, Giovanni;D'Avolio, Antonio
Last
2018-01-01

Abstract

Since HCV infection may lead to hepatocellular carcinoma (HCC) and vitamin D (deficiency) is related to cancer, we investigated if SNPs in genes involved in vitamin D pathway could predict HCV-related HCC presence in patients treated with new anti-HCV drugs.
2018
81
3
615
620
Hepatocellular carcinoma; Pharmacogenetics; SNP; Sofosbuvir; VDR; Viral hepatitis; Vitamin D
Cusato, Jessica; Boglione, Lucio; De Nicolò, Amedeo; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Guido, Federica; Avataneo, Valeria; Ca...espandi
File in questo prodotto:
File Dimensione Formato  
10.1007%2Fs00280-018-3520-0 (1).pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 901.44 kB
Formato Adobe PDF
901.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1661730
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact